Deerfield Management Co. LP, of New York, said it closed an $840 million Deerfield Healthcare Innovations Fund ll, which will invest in advancements in science that may lead to important therapeutic interventions and back new technologies and infrastructure to improve the way health care is delivered to patients.

Kala Pharmaceuticals Inc., of Watertown, Mass., said the underwriters of its underwritten public offering of common stock have exercised a portion of their option to purchase additional shares of common stock. The 979,371 additional shares sold brought the total number of shares of common stock sold in the offering to 16.97 million for aggregate gross proceeds of approximately $134 million.

No Comments